| Bioactivity | (R)-Irsenontrine ((R)-E2027), the R-enantiomer of Irsenontrine (HY-132821), is a potent phosphodiesterase 9 (PDE9) inhibitor with an IC50 value of 0.041 μM. (R)-Irsenontrine can be used for the research of neurological diseases[1]. |
| Name | (R)-Irsenontrine |
| CAS | 1429509-81-8 |
| Formula | C22H22N4O3 |
| Molar Mass | 390.44 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
| Reference | [1]. Yoshihiko N, et, al. Pyrazoloquinoline derivative. WO2013051639A1. |
(R)-Irsenontrine
CAS: 1429509-81-8 F: C22H22N4O3 W: 390.44
(R)-Irsenontrine ((R)-E2027), the R-enantiomer of Irsenontrine (HY-132821), is a potent phosphodiesterase 9 (PDE9) inhib
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.